Adipocyte maturation arrest: A determinant of systemic insulin resistance to glucose disposal

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 3, 2012, Pages 760-763

  Abate, Nicola ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; GLUCOSE; INSULIN; TRIACYLGLYCEROL;

ADIPOCYTE; BODY FAT DISTRIBUTION; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL MATURATION; EDITORIAL; FOOD INTAKE; GLUCOSE METABOLISM; GLUCOSE UTILIZATION; GROWTH INHIBITION; HUMAN; INSULIN RESISTANCE; LIPID METABOLISM; LIPID STORAGE; LIPOTOXICITY; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOGENESIS; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RISK FACTOR; WAIST CIRCUMFERENCE; WEIGHT GAIN;

ADIPOSE TISSUE; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INSULIN RESISTANCE; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 84858052778     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-1140     Document Type: Editorial

References (25)

1. Del Prato S 2009 Role of glucotoxicity and lipotoxicity in the pathophysiology of type 2 diabetes mellitus and emerging treatment strategies. Diabet Med 26:1185-1192
2. Unger RH, Clark GO, Scherer PE, Orci L 2010 Lipid homeostasis, lipotoxicity and the metabolic syndrome. Biochim Biophys Acta 1801:209-214
3. Abate N 1996 Insulin resistance and obesity. The role of fat distribution pattern. Diabetes Care 19:292-294 (Pubitemid 26070359)
4. DeFronzo RA 2010 Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009. Diabetologia 53:1270-1287
5. Grundy SM 2004 Obesity, metabolic syndrome, and cardiovascular disease. J Clin Endocrinol Metab 89:2595-2600 (Pubitemid 38766337)
6. Zavaroni I, Bonora E, Pagliara M, Dall'Aglio E, Luchetti L, Buonanno G, Bonati PA, Bergonzani M, Gnudi L, Passeri M, Reaven G 1989 Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl J Med 320: 702-706 (Pubitemid 19072489)
7. Grundy SM, Brewer Jr HB, Cleeman JI, Smith Jr SC, Lenfant C 2004 Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109:433-438 (Pubitemid 38133916)
8. Haffner SM, D'Agostino R, Saad MF, Rewers M, Mykkänen L, Selby J, Howard G, Savage PJ, Hamman RF, Wagenknecht LE 1996 Increased insulin resistance and insulin secretion in nondiabetic African- Americans and Hispanics compared with non-Hispanic whites. The Insulin Resistance Atherosclerosis Study. Diabetes 45: 742-748
9. Chandalia M, Lin P, Seenivasan T, Livingston EH, Snell PG, Grundy SM, Abate N 2007 Insulin resistance and body fat distribution in South Asian men compared to Caucasian men. PLoS ONE 2:e812
10. Alberti KG, Zimmet P, Shaw J 2005 The metabolic syndrome-a new worldwide definition. Lancet 366:1059-1062 (Pubitemid 41338752)
11. Rogers C, Moukdar F, McGee MA, Davis B, Buehrer BM, Daniel KW, Collins S, Barakat H, Robidoux J 2012 EGF receptor (ERBB1) abundance in adipose tissue is reduced in insulin-resistant and type 2 diabetic women. J Clin Endocrinol Metab 97:E329-E340
12. Pan W, Ciociola E, Saraf M, Tumurbaatar B, Tuvdendorj D, Prasad S, Chandalia M, Abate N 2011 Metabolic consequences of ENPP1 over-expression in adipose tissue. Am J Physiol Endocrinol Metab 301:E901-E911
13. Bays H, Abate N, Chandalia M 2005 Adiposopathy: sick fat causes high blood sugar, high blood pressure and dyslipidemia. Future Cardiol 1:39-59
14. Reaven G 2005 All obese individuals are not created equal: insulin resistance is the major determinant of cardiovascular disease in overweight/obese individuals. Diab Vasc Dis Res 2:105-112 (Pubitemid 41695168)
15. Wildman RP, Muntner P, Reynolds K, McGinn AP, Rajpathak S, Wylie-Rosett J, Sowers MR 2008 The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med 168:1617-1624
16. Perseghin G 2011 Lipids in the wrong place: visceral fat and nonalcoholic steatohepatitis. Diabetes Care 34(Suppl 2):S367-S370
17. van der Zijl NJ, Goossens GH, Moors CC, van Raalte DH, Muskiet MH, Pouwels PJ, Blaak EE, Diamant M 2011 Ectopic fat storage in the pancreas, liver, and abdominal fat depots: impact on β-cell function in individuals with impaired glucose metabolism. J Clin Endocrinol Metab 96:459-467
18. Li S, Brown MS, Goldstein JL 2010 Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis. Proc Natl Acad Sci USA 107:3441-3446
19. Aly FZ, Kleiner DE 2011 Update on fatty liver disease and steatohepatitis. Adv Anat Pathol 18:294-300
20. Cali AM, Caprio S 2009 Ectopic fat deposition and the metabolic syndrome in obese children and adolescents. Horm Res 71(Suppl 1):2-7
21. Fabbrini E, Sullivan S, Klein S 2010 Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology 51:679-689
22. Samuel VT, Petersen KF, Shulman GI 2010 Lipid-induced insulin resistance: unravelling the mechanism. Lancet 375:2267-2277
23. Volovelsky O, Weiss R 2011 Fatty liver disease in obese children-relation to other metabolic risk factors. Int J Pediatr Obes 6(Suppl 1):59-64
24. Yki-Järvinen H 2010 Liver fat in the pathogenesis of insulin resistance and type 2 diabetes. Dig Dis 28:203-209
25. Boden G, Chen X 1995 Effects of fat on glucose uptake and utilization in patients with non-insulin-dependent diabetes. J Clin Invest 96:1261-1268